Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

MD-Education logo
Register / Login
We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


Inaugural

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


GI Cancers

US Focus Meeting

Updating Knowledge & Clinical Practice in 2025


Marina del Rey Marriot, 4100 Admiralty Way, Marina Del Rey, CA 90292

July 25 - 26, 2025

Interested in supporting this meeting? Reach out to us here:

=

Co-chair

Tanios Bekaii-Saab, MD

Mayo Clinic, Phoenix, AZ

=

Co-chair

Eileen M. O’Reilly, MD

Memorial Sloan Kettering Cancer Center, New York, NY

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress GI Cancers US Focus 2025, to be held at Marina del Rey Marriot, 4100 Admiralty Way, Marina Del Rey, CA 90292 on July 25th, 2025 to July 26th, 2025.


This meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.


This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.



People stood in a circle, smiling, with a cup of water

Agenda & Faculty

GI Cancers US Focus Meeting, Friday, July 25, 2025 - Saturday, July 26, 2025

8:00 AM

Registration Opens

Session 1: Pancreas Cancer

9:00 AM

First-line Chemotherapeutic Options in mPDAC

=

Shubham Pant, MD

MD Anderson Cancer Center, Houston, TX

9:20 AM

RAS Directed-Therapies in mPDAC

=

Eric Collisson, MD

Fred Hutchinson Cancer Center, Seattle, WA

9:40 AM

Targeted (Excluding RAS Directed) Therapies in mPDAC

=

Michael Pishvaian, MD

Johns Hopkins Kimmel Cancer Center, Washington, D.C.

10:00 AM

Panel Discussion

10:30 AM

Coffee Break

Session 2: Biliary Tract Cancers (BTC)

10:50 AM

Immunotherapy Options in Advanced BTC

=

Mitesh Borad, MD

Mayo Clinic, Phoenix, AZ

11:10 AM

HER2 Targeted Therapies in Advanced BTC

=

James Harding, MD

Memorial Sloan Kettering Cancer Center, New York, NY

11:30 AM

Emerging Treatment landscape in Early-stage BTC

=

Jennifer Knox, MD

Princess Margaret Cancer Centre, Toronto, Canada

11:50 AM

Panel Discussion

12:20 PM

Industry Supported Independent Expert Discussion

1:05 PM

Lunch Break + Faculty and Fellow Photo

Session 3: Hepatocellular Cancer (HCC)

1:55 PM

Navigating First-line Treatment Options in HCC

=

Anthony El-Khoueiry, MD

USC Norris Comprehensive Cancer Center, Los Angeles, CA

2:15 PM

Second-line Options in HCC in the Era of Immunotherapy

=

Richard Finn, MD

UCLA Health, Los Angeles, CA

2:35 PM

Integrating Systemic Therapy in Early-stage HCC

=

Ghassan Abou-Alfa, MD

Memorial Sloan Kettering Cancer Center, New York, NY

2:55 PM

Panel Discussion

3:25 PM

Coffee Break

Session 4: Neuroendocrine Tumors (NET)

3:45 PM

The Role of Peptide Receptor Radionuclide Therapy (PRRT) in NET

=

Thorvadur Halfdanerson, MD

Mayo Clinic, Rochester, MN

4:05 PM

The Role of TKIs in NET

=

Jennifer Chan, MD

Dana-Farber Cancer Institute, Boston, MA

4:25 PM

Systemic Therapy Opportunities in Early-stage NET

=

Mohamad Bassam Sonbol, MD

Mayo Clinic, Phoenix, AZ

4:45 PM

Panel Discussion & Take-home Points from Day 1

5:15 PM

Adjourn